Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Rate of elimination of the disease-producing bacteria identified at the start of the study; signs and symptoms and microscopic evidence of cure
Physical examinations including examination of the muscles, joints, and bones; vital sign measurements, laboratory tests, and incidence of adverse events including any report of joint pain or joint disease
6 Months to 5 Years (Child)
September 4, 2002
June 8, 2011
† Study has passed its completion date and status has not been verified in more than two years.